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Abstract
High-throughput sequencing assays are now routinely used to study different aspects of genome organization. As
decreasing costs and widespread availability of sequencing enable more laboratories to use sequencing assays in
their research projects, the number of samples and replicates in these experiments can quickly grow to several
dozens of samples and thus require standardized annotation, storage and management of preprocessing steps. As a
part of the STATegra project, we have developed an Experiment Management System (EMS) for high throughput
omics data that supports different types of sequencing-based assays such as RNA-seq, ChIP-seq, Methyl-seq, etc, as
well as proteomics and metabolomics data. The STATegra EMS provides metadata annotation of experimental
design, samples and processing pipelines, as well as storage of different types of data files, from raw data to ready-to-
use measurements. The system has been developed to provide research laboratories with a freely-available,
integrated system that offers a simple and effective way for experiment annotation and tracking of analysis
procedures.
Background
The widespread availability of high-throughput sequen-
cing techniques have importantly impacted genome
research and reshaped the way we study genome function
and structure. The rapidly decreasing costs of sequencing
make these technologies affordable to small and medium
size laboratories. Furthermore, the constant development
of novel sequencing based assays, coined with the suffix
-seq, expands the scope of cellular properties analyzable
by high-throughput sequencing, with sequencing reads
forming an underlying common data format. Today, vir-
tually all nucleic acid omics methods traditionally based
on microarrays have a -seq counterpart and many more
have been made available recently. As a consequence, the
possibility of running multiple sequencing-based experi-
ments to measure different aspects of gene regulation
and combining these with non-sequencing omics tech-
nologies such as proteomics and metabolomics has
become practical [1-5]. For example, the ENCODE
project combined ten major types of sequencing-based
assays to unravel the complexity of genome architecture
[6]. Many records can be found at the SRA archive that
integrate multiple -seq technologies measured on the
same samples and a PubMed search for NGS plus pro-
teomics or metabolomics results in over hundred entries.
Last but not least, one of the advantages of sequenced-
based experiments is that they are equally applicable to
the study of well-annotated model organisms as well as
less-studied non-model organisms since little or no a
priori genome knowledge is required.
Moreover, sequencing-based assays come with new
challenges for data processing and storage. The memory
size requirements of a medium sequencing experiments
exceeds the capacity of current regular workstations. At
the same time, the analysis steps to go from raw to pro-
cessed data are more complex and resource intensive. As
the number of datasets grows, the need to properly store
and track the data and their associated metadata becomes
more pressing. For example, a medium-sized RNA-seq
experiments ranging between 4 to 20 samples of 20 million
reads each can take up to 40 GB of raw data and generate
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multiple Quality Control and intermediate processing step
files of up to 200 to 500 GB. Laboratory Information and
Management Systems (LIMS) or Sample Management
Systems (SMS) are bioinformatics tools that aid experi-
mentalists to organize samples and experimental proce-
dures in a controlled and annotated fashion. There are
several commercial and free dedicated LIMS that have
been developed specifically for genotyping labs where thou-
sand of samples are processed by automated pipelines and
procedures are tightly standardized [7-9]. One popular
LIMS for genomics is BASE [10]. This software includes a
highly structured system for metadata annotation and a
flexible architecture for defining experiments and incorpor-
ating analysis modules. However, BASE is currently
restricted to the annotation of microarray experiments.
Several laboratory information systems have been
developed and implemented specifically for samples at
sequencing facilities to manage the large volume of sam-
ples and data routinely handled by such services. Some of
these have been made available to the scientific commu-
nity or exported to other centers [11] published an exten-
sion of the Protein Information Management System
(PIMS) for the Leeds University DNA sequencing facility
designed to provide sample tracking both to users and
operators. The system allows facility users to place orders
and monitor the processing status of their samples while
a different interface provides operators with a full control
on the progression of the sequencing pipeline with auto-
mated connection to sequencing robots. The Leeds sys-
tem supervises the whole procedure from sample
submission to generation of fastq files but does not track
the actual experimental characteristics of the sequenced
samples or the post-processing of the raw data. Other
solutions add to the tracking of sequencing samples ana-
lysis modules that execute some steps of the raw data
processing such as Quality Control analysis or mapping
to a reference genome. For example, the QUEST software
[12] uses an experiment-resolved configuration file to
store experiment metadata and execute predefined pro-
cessing pipelines. Another example is NG6 [13] an inte-
grated NGS storage and processing environment where
workflows can be easily defined and adapted to different
data input formats. NG6 can be used interactively to gen-
erate intermediate analysis statistics and downloadable
end results. Similarly, Scholtalbers et al. recently pub-
lished a LIMS for the Galaxy platform that keeps track of
input sample quality and organize flow cells [14]. By
working within the Galaxy system, associated fastq files
are readily available for processing using the platform’s
analysis resources. Another interesting package is the
MADMAX system that considers multiple omics experi-
ments by incorporating modules for microrarrays, meta-
bolomics and genome annotation [15]. MADMAX uses
an Oracle relational database to store sample and raw
data, and links to common bioinformatics tools such as
Blast or Bioconductor installed on a computer cluster to
facilitate data analysis.
We describe the STATegra Experiment Management
System (EMS), which is an information system for sto-
rage and annotation of complex NGS and omics experi-
ments. In contrast to other solutions that put the focus
on management of thousands of samples for core
sequencing facilities, the STATegra EMS has as primary
goal the annotation of experiments designed and run at
individual research laboratories. The system contains
modules for the definition of omics experiments, samples
and analysis workflows and it is able to incorporate data
from different analytical platforms and sequencing ser-
vices with great flexibility. The STATegra EMS supports
currently mRNA-seq, ChIP-seq, DNase-seq, Methyl-seq,
miRNA-seq, Proteomics and Metabolomics by default
and can be easily adapted to support additional high-
throughput experiments. The system uses free, open
source software technologies, such as Java Servlets, the
Sencha EXT JS framework, MySQL relational database
system and the Apache Tomcat Servlet engine. The




The STATegra EMS was designed as a multiuser web
application and is divided in two components: the SER-
VER SIDE application and the CLIENT SIDE web applica-
tion (Figure 1).
The server side is the responsible for keeping the con-
sistency of data and for controlling the access to the
stored information, is built using Java Servlets and a
MySQL relational database and is unique for all clients.
Although primarily designed and tested on Linux ser-
vers, the server EMS code could easily be adapted to
work over other architectures due to the cross-platform
nature of Java. Additionally, the server code was imple-
mented using the Data Access Object design pattern in
conjunction with the Data Transfer Object pattern. This
provides an abstraction layer for interaction with data-
bases that acts as an intermediary between server appli-
cation (servlets) and the MySQL database, making easier
future extensions of the application code with new fea-
tures or changes in the database model.
The STATegra EMS client side was developed as user-
friendly and intuitive web application using Ext JS, a
cross-browser JavaScript framework which provided
powerful tools for building interactive web applications.
The client side is based on the Model-View-Controller
architecture pattern, which make easier to organize,
maintain and extend large client applications. Commu-
nication between Client and Server side is handled by
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AJAX and HTTP GET and POST protocols using Java-
Script Object Notation (JSON) for data exchange.
User administration
The STATegra EMS is a system with user control. Users
should be registered by the Administrator in the applica-
tion before start working. As a general rule, the user creat-
ing a data element becomes the owner of this element and
has exclusive rights for editing and deleting. However, any
owner can grant access rights to other registered users of
the system.
Data specification
The overall objective of the STATegra EMS is to serve as
a logbook for high-throughput genomics projects per-
formed at research labs by providing an easy-to-use tool
for the annotation of experimental design, samples, mea-
surements, and the analysis pipelines applied to the data.
Experimental data and metadata are organized in the
EMS around three major metadata modules (Figure 2):
the Experiment module that records experimental design
information and associated samples; the Samples module
that collects all information on the used biomaterial; and
the Analysis module that contains analysis pipelines and
results. Both Sample and Analysis modules have been
defined broadly to accommodate data from different type
of omics experiments and still provide a common anno-
tation framework. Commonly used standards in omics
experimental data annotations were used when defining
data specifications to facilitate EMS interoperability. In
particular, we leveraged MIAPE [16] for proteomics ana-
lysis annotation, metabolomics guidelines proposed by
[17] and [18] and MIAME [19] and MINSEQE [20] for
sequencing experiments.
Sample and Analysis modules contain distinct Informa-
tion Units (IUs), which are the basic elements of data
input into the system and are connected by an experimen-
tal or analysis workflow. The Experiment Module is a
wrapper of Samples and Analyses with one single data
input form.
Figure 1 Overview of the STATegra EMS architecture.
Figure 2 Metadata Module structure in STATegra EMS. The Sample module stores information of biological conditions, biological replicates
and the associated analytical samples. The analysis module contains all analysis steps from raw to processed data. Both samples and analyses
are associated to one or more experiments within the Experiment module.
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(i) Experiment module: The experiment is the central
unit of information of the STATegra EMS. An Experiment
is defined by some scientific goals and a given experimen-
tal design that addresses these goals. This design implies a
number of biological samples and an array of omics mea-
surements, which are assigned to the Experiment.
(ii) Sample module. This section hosts the information
about biological conditions and their associated biological
replicates and analytical samples. The IUs of this module
are:
Biological Condition. These are defined by the experi-
mental design and consist of a given biological material
such as the organism, cell type, tissue, etc. and, when
applicable, an experimental condition such as treatment,
dose or time-point for time-series samples.
Biological Replicate. Each Biological Condition is
assessed by using one or more biological replicates that
may or may not correspond to the same experimental
batch. The Biological Replicate stems directly from Biolo-
gical Condition by adding a replicate number and, if
applicable, a batch number.
Experimental Batch. Frequently, when an experiment is
composed of a large number of samples, only some of
them can be generated at the same time. These samples
correspond to the same batch. Batch information is rele-
vant to identify systematic sources of noise that might
affect all samples within the batch.
Analytical Sample. Omics experiments analyze mole-
cular components of biological samples using a given
experimental protocol with the resulting analytical sam-
ple ready-to-be-measured by the high-throughput tech-
niques. For example, a RNA-seq analytical sample is
obtained after using a cytosolic mRNA extraction proto-
col. Similarly for metabolomics, different analytical sam-
ples can be obtained by applying multiple extraction
protocols that target distinct metabolic compounds.
(iii) Analysis module. The Analysis module stores high-
throughput molecular data obtained by the omics tech-
nologies and the data generated after processing of the
primary raw data files. In contrast to the Sample module
where only metadata is stored, the Analysis module also
stores pointers to data files. The Analysis module consists
of three data and one logical IUs:
Raw Data. These files contain the data as produced by
the omics equipment. For example, fastq files in the case
of sequencing experiments and NMR .raw files in the case
of metabolomics experiments. The Raw data IU also con-
tains detailed information of the experimental protocol
applied to the analytical sample, i.e., the library prepara-
tion protocol followed in a RNA-seq experiment or the
NMR analysis characteristics in the case of metabolomics.
Intermediate Data. This IU covers all processing steps
from raw data to process data. Different omics experiment
might require zero, one, or several intermediate steps. For
example, in the case of RNA-seq, the mapping to a refer-
ence genome that produces a bam file constitutes an
intermediate step. ChIP-seq will generally have two inter-
mediate steps consisting of read mapping and peak calling.
Processed Data. The Processed data IU contains the
final processing step that result in a data file containing
the final signal values for the omics assay.
Analysis. The STATegra EMS includes an additional
IU, the Analysis, which is constructed by connecting
some of the previous data IUs to define a data processing
workflow. Figure 3 shows a generic representation of the
workflow elements used in sequencing data analyses. An
Analysis will start on a raw data file obtained from a par-
ticular analytical sample, continue through one or several
intermediate data files covering different processing steps
(such as trimming, mapping, filtering, merging, etc), and
finalize in a processed data file that contain the signal
values of the omics features. Alternatively, an Analysis
can take as input a processed data file and apply addi-
tional processing steps to render a higher-level processed
data. For example, in DNase-seq analysis, a primary
workflow would be to call DNase hypersensitivity regions
(DHR) by applying a peak-calling algorithm to a BAM
file of mapped reads (Figure 4A); whereas a secondary
Analysis could involve merging DHR.bed files from N
different samples to obtain a set of consolidated regions
and then counting the number of reads of each sample in
the consolidated region set to generate a per-sample sig-
nal value file (Figure 4B).
In terms of data consistency, a unique Analysis ID is
always associated to one Processed Data ID and describes
the set of steps involved in obtaining that particular pro-
cessed data. Moreover, an Analysis is always associated to
one or more Experiments and, since the Analysis workflow
can be traced back to raw data and its associated analytical
samples, the Analysis provides the link between the
Experiment and the Sample modules. By default, when a
new Analysis is created, it will be assigned to the currently
active Experiment. Figure 5 shows the data input window
at the Analysis module. The central panel displays the
input form for the different analysis steps, while at the bot-
tom a graphical representation of the workflow allows




To illustrate the usage and functionalities of the STATegra
EMS, we consider the registration into the system of a
subset of the ENCODE human dataset [21] comprising
the four omics data types (mRNA-seq, ChIP-seq, DNase-
seq and Proteomics) of two cell lines GM12878 and K562,
with two biological replicates for most data types.
ENCODE cell lines were regularly cultured in batches at
Hernández de Diego et al. BMC Systems Biology 2014, 8(Suppl 2):S9
http://www.biomedcentral.com/1752-0509/8/S2/S9
Page 4 of 10
data production labs to generate the samples for the differ-
ent sequencing assays. In our example, we consider the
utilization of one or several biological replicates from the
same batch to obtain the analytical samples for ChIP-seq
and proteomics experiments as depicted in Figure 6. An
instance of the STATegra EMS with the ENCODE test
data fully annotated into the system can be accessed at
http://stategra.eu/stategraems_test.
At the Experiment Module a new experiment is cre-
ated by the Experiment owner who assigns registered
users to it. The Experiment has a unique ID within the
system along with some basic information such as goal,
description, type of experiment, experimental design and
planned omics measurement types. Check boxes next to
each planned measurement are available to monitor the
progress of the experiment. These are automatically
checked when a matching Analysis is uploaded and
assigned to the Experiment. Figure 7 shows the Experi-
ment annotation for our use case: a human-readable
name (ENCODE test) and description (STATegra EMS
test experiment) are given for the experiment, and the
basic experimental details are indicated: multiple
Figure 3 STATegra EMS analysis workflow components. The workflow is linked to an analytical sample object and consists of raw,
intermediate and processed data IUs.
Figure 4 Example of primary and secondary workflow for a DNase-seq analysis . Primary workflow (a) involves calling DNase
hypersensitivity regions (DHR) by applying a peak-calling algorithm to a BAM file of mapped reads whereas secondary workflow (b) involves
merging of DHR.bed files from different samples to obtain a set of consolidated regions and then counting the number of reads of each sample
in the consolidated region set to generate a per-sample signal value file.
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Figure 5 Analysis module input window.
Figure 6 Sample scheme for cell line K562 ENCODE user case data. See main text for description.
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conditions experiment type, two biological replicates and
three omics types, mRNA-seq, ChIP-seq, DNase-seq and
proteomics.
Users then fill the Sample Module input form (Figure 8).
The first of four sections of this form includes fields for
General information on the sample such as sample ID
(auto_generated), sample name (K562 or GM12878) and
title, which is a more extended description of the sample
(Chronic myelogenous leukemia/Lymphoblastoid). The
second section of the form is used to describe the Bioma-
terial. For this use case, we entered the lymphocyte cell
type from the blood tissue in human, with GM12878 as
normal and K562 as cancer variation. The Experimental
condition section is left blank in this example, since our
cell lines did not receive any particular treatment. The next
section records the associated Biological Replicates, where
we can add items when more than one biological replicate
is available for the same biological condition. For this user
case, we created nine biological replicates to implement the
scheme in Figure 6 and indicated the number for each
replicate (i.e. #1), the corresponding batch when applicable,
and its derived analytical samples. Analytical samples are
characterized by an extraction protocol and a name. Multi-
ple analytical replicates can be created for one biological
replicate. For example, the RNA-seq data in our use case
has one Analytical sample per each of the two biological
replicates obtained with the Caltech long mRNA extraction
protocol, while the proteomics data includes four analytical
samples corresponding to each sub-cellular fraction (mem-
brane fraction, cytosol, nucleus, mitochondria) (Figure 6).
Finally, information about the processing workflows is
incorporated in the Analysis module. While the use case
involves four omics types, we will only describe the
RNA-seq workflow in detail, as the Chip-seq, DNase
and Proteomics workflows are conceptually similar.
Within the active experiment, a new Analysis is selected,
indicating mRNA-seq as the analysis type. Clicking on the
“Annotate new step” adds each new analysis step. At the
beginning of an Analysis “Raw Data” is the only option
available, which opens the Raw Data form. At this point
the user selects an existing Analytical Sample ID to start
annotating the library preparation details and sequencing
characteristics of a particular sample. In our example, we
would choose the Analytical Sample #1 corresponding to
Biological Replicate #1 of the K562 cell line. Additionally
we can indicate the location of the raw data fastq file in
our system. In principle the EMS does not stores any raw
or processed data files, and instead provides pointers to
the location of these files. Once the Raw Data form is
completed and saved, a graphical representation of the
analysis workflow is created on the lower screen window
of the Analysis Module (Figure 5). This workflow will
grow with the subsequent analysis steps. After the Raw
Data step is created, additional intermediate steps can be
added. In our user case, the next intermediate step to add
is the mapping of the reads to the human reference
genome, where the user would indicate which raw data
file was used and other parameters such a reference gen-
ome annotation file or mapping algorithm such as GEN-
CODE hg19 and TopHat respectively. Other subsequent
Figure 7 Annotation details at Experiment module.
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intermediate steps can be envisioned such as trimming,
removal of duplicate reads, etc. The analysis workflow
ends with a Processed Data step with a form that requires
annotation of a previous intermediate or raw data steps.
For RNA-seq, one Processed Data step could for example
correspond to the Cufflinks gtf file with FPKMs. A com-
pleted Analysis can be partially reused and modified to
create additional workflows such as one leading to a
Figure 8 Sample form. The sample form provides fields to annotate biological condition details including data on the associated biological
replicates and analytical samples.
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different Processed Data step. For example, the first two
steps of the previous analysis workflow can be imported to
create a new workflow having a different Processed Data
step recording a junction’s bed file obtained by TopHat.
Conclusion
As high-throughput sequencing costs decrease and new
sequencing-based molecular assays become available more
research laboratories incorporate the NGS technology as a
tool to address their scientific goals. This is additionally
promoted by the fact that high-throughput sequencing is
also feasible in organisms with very little genome informa-
tion. In a typical scenario, the researcher plans and out-
sources his/her experiments to sequencing facilities that
might vary over time or according to the specific NGS
assay required. When sequencing results arrive and accu-
mulate, a necessity arises to properly store and organize
large datasets and their associated processing pipelines.
The STATegra EMS has been conceived to provide a
management solution in these cases. The architecture of
the system was designed having in mind the situation at
research labs, where multiple experiments are run, sam-
ples might be replicated of reused in successive experi-
ments, and one same biomaterial source could be used for
different types of NGS assays. For this, the Sample Module
arranges annotation into three Information Units: biologi-
cal condition, biological replicate and analytical sample
allowing one to many relationships, which creates the flex-
ibility to define complex sampling settings without dupli-
cation of information. Similarly, the Analysis module
divides metadata annotation into steps that can be reused
to create alternative analysis workflows. Finally, by allow-
ing samples and analyses to belong to different experi-
ments, the STATegra EMS can accommodate possible
connections between experiments.
This architecture is substantially different from other
information management solutions created for NGS data
that are oriented to sequencing facilities, such as the
Galaxy LIMS [14] which handles requests from users to
the service, or the NG6 [13] that controls the sequencing
workflow at sequencing providers. In these cases the man-
agement system is adapted to the production pipeline at
the sequencing center and applies a strong control on the
facility wet-lab including library preparation and sequen-
cer runs. This type of information is absent from the STA-
Tegra EMS, which may actually accept data from multiple
sequencing providers. On the contrary the STATegra
EMS records experimental information and sample meta-
data that might not be relevant at a production center. In
conclusion, NGS LIMS and the STATegra EMS target dif-
ferent users and needs in the management of sequencing
data. An open challenge is yet to optimize the integration
of -seq data with clinical information similarly to what is
done in clinical development centers [22,23].
The current STATegra EMS supports analysis work-
flows for five popular sequencing functional assays but can
easily be extended to other *seq applications as processing
step forms are generic for DNA and cDNA high-through-
put sequencing. Additionally, the system supports annota-
tion of omics experiments targeting non nucleic acid
components, such as proteomics and metabolomics for
which specific input forms have been incorporated. All
together, the STATegra EMS provides an integrated sys-
tem for annotation of complex high-throughput omics
experiments at functional genomics research laboratories.
Availability and requirements
The STATegra EMS application is distributed under GNU
General Public License, Version 3 and can be obtained
from http://stategra.eu/stategraems. The STATegra EMS
was developed in JAVA and is therefore platform indepen-
dent, but it has only been extensively tested for UNIX
environments. The software MySQL server and Apache
Tomcat. Installation instructions can be found at http://
stategra.eu/stategraems_installation.
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